ARHGAP35 and neoplasm: Moreover, intratumoural administration of p190RhoGAP siRNA reduced tumour growth (Supplementary Fig. 2a) and proliferative rate of tumours (Supplementary Fig. 2b) whereas induced apoptosis in tumour cells (Supplementary Fig. 2c).